Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy‐Mee Yu, Philip Evans, Dan V. Nicolau et al.|The Lancet|2021Cited by 310
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Victoria Glover et al.|The Lancet Respiratory Medicine|2023Cited by 70